Xiao Shi

机构：Fudan University Shanghai Cancer Center, Nanjing Drum Tower Hospital, Io Therapeutics (United States) · ORCID：0000-0002-6803-7438

发表论文 68 篇 · 总被引 1478 次 · h-index 18

代表论文

• A distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy sensitive than papillary thyroid cancer (2024 · JCI Insight · 被引 51)
• A spatially resolved transcriptome landscape during thyroid cancer progression (2025 · Cell Reports Medicine · 被引 30)
• Hemithyroidectomy Versus Total Thyroidectomy for Sporadic Medullary Thyroid Cancer: A Chinese Nationwide Large-Scale Cohort Study (2025 · Journal of the National Comprehensive Cancer Network · 被引 17)
• Updated Thresholds of Basal Calcitonin Level and Extent of Lymph Node Metastasis in Initially Treated Medullary Thyroid Cancer (2025 · JAMA Otolaryngology–Head & Neck Surgery · 被引 15)
• Comprehensive DNA Methylation Profiling of Medullary Thyroid Carcinoma: Molecular Classification, Potential Therapeutic Target, and Classifier System (2023 · Clinical Cancer Research · 被引 11)
• Evaluation of the anti-tumor effect of gambogic acid loaded macrophage membranes nanoparticles combined with radiotherapy and anti-PD-1mAb in the colorectal cancer with liver metastasis model (2025 · Biomaterials Advances · 被引 4)